Julia Manasson, MD, MS

Seismic Therapeutic
New York, New York, United States

I am Medical Director of Patient Biology at Seismic Therapeutic.

0008: Characterization of S-1117, a novel pan-IgG protease engineered for reduced immunogenicity using the IMPACT platform

Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): Seismic Therapeutic: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
0987: S-4321, a novel dual-cell bifunctional PD-1:FcγRIIb selective agonist antibody for autoimmune disease, maintains expression of PD-1 on target cells and enhances inhibitory receptor expression on T cells in vivo

Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): Seismic Therapeutic: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)